Please assess the completion status of the following clinical trial:

Trial Title: Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Signed Letter of Content~* diagnosis of ulcerative colitis (clinical, endoscopic and histologic evidence)~* chronic active and steroid dependent course over at least 4 months (CAI \> 4, EAI \> 4)~Exclusion Criteria:~* infectious colitis~* toxic megacolon~* ulcerative proctitis or less than 20cm inflamed

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).